Wockhardt · NSE: WOCKPHARMA · BSE: 532300
Q4 FY19 results · Jan–Mar 2019
Wockhardt reported revenue from operations of ₹979.13 crore and net loss of ₹13.90 crore for Q4 FY19 (Jan–Mar 2019), on a consolidated basis.
| Item | Q4 FY19 | Q4 FY18 | YoY | Q3 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 979.13 | — | — | 1,045.86 | −6.4% |
| Other income | 5.42 | — | — | 2.08 | +160.6% |
| Total income | 984.55 | — | — | 1,047.94 | −6.0% |
| Profit before tax | (48.00) | — | — | (120.59) | Loss narrowed |
| Net profit for the period | (13.90) | — | — | (76.86) | Loss narrowed |
| Attributable to shareholders of the company | (14.47) | — | — | — | — |
| EPS, basic (₹) | (1.31) | — | — | (6.42) | Loss narrowed |
| Net margin (%) | -1.4 | — | -7.3 |
| Item | Q4 FY19 | Q4 FY18 | YoY | Q3 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 467.40 | — | — | 508.60 | −8.1% |
| Other income | 8.39 | — | — | 5.90 | +42.2% |
| Total income | 475.79 | — | — | 514.50 | −7.5% |
| Profit before tax | (82.73) | — | — | (84.40) | Loss narrowed |
| Net profit for the period | (33.52) | — | — | (38.36) | Loss narrowed |
| EPS, basic (₹) | (3.03) | — | — | (3.46) | Loss narrowed |
| Net margin (%) | -7.2 | — | -7.5 |
Consolidated
- Filed with BSE
- 07 May 2019, 10:52 IST
- Board meeting
- 06 May 2019
- Period
- 01 Jan 2019 to 31 Mar 2019
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 07 May 2019, 10:52 IST
- Board meeting
- 06 May 2019
- Period
- 01 Jan 2019 to 31 Mar 2019
- Review status
- Audited
- Source
- XBRL filing on BSE